Edition:
United Kingdom

MDxHealth SA (MDXH.BR)

MDXH.BR on Brussels Stock Exchange

3.74EUR
3:32pm GMT
Change (% chg)

€-0.10 (-2.60%)
Prev Close
€3.84
Open
€3.88
Day's High
€3.88
Day's Low
€3.72
Volume
136,866
Avg. Vol
119,477
52-wk High
€5.78
52-wk Low
€3.63

Select another date:

Mon, Nov 20 2017

BRIEF-MDxHealth teams up with Ferrer for distribution of its prostate cancer test SelectMDx in Spain

* REG-MDXHEALTH TEAMS UP WITH PHARMACEUTICAL COMPANY FERRER FOR DISTRIBUTION OF ITS PROSTATE CANCER TEST SELECTMDX IN SPAIN

BRIEF-MDX Pcl posts ‍qtrly net profit of 86.1 mln baht

* ‍Qtrly net profit 86.1 million baht versus 19.8 million baht Source text for Eikon: Further company coverage:

BRIEF-MDxHealth 9M total revenue at 30.5 million dollars

* 9M (NOT Q3) NET LOSS $‍​7.4 MILLION VERSUS LOSS OF $10.3 MILLION YEAR AGO

BRIEF-MDxhealth enters distribution agreement with Unilabs for SelectMDx

* ‍MDXHEALTH ENTERS INTO DISTRIBUTION AGREEMENT WITH UNILABS FOR SELECTMDX FOR PROSTATE CANCER ​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-MDxHealth opens new laboratory in the Netherlands

* MDXHEALTH OPENS NEW SERVICE AND RESEARCH LABORATORY IN THE NETHERLANDS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-MDxHealth appoints Michael K. Brawer as Chief Medical Officer‍​

* ANNOUNCES APPOINTMENT OF MICHAEL K. BRAWER, MD AS CHIEF MEDICAL OFFICER‍​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-MDxHealth H1 EBITDA rises to 1.4 million dollars

* H1 ‍TOTAL REVENUE OF $24.3 MILLION, UP 87% FROM $12.9 MILLION IN 2016​

BRIEF-MDxHealth announces ConfirmMDx study provides further validation of epigenetic risk profile

* REG-CONFIRMMDX STUDY PROVIDES FURTHER VALIDATION OF EPIGENETIC RISK PROFILE

REFILE-BRIEF-MDxHealth signs service agreement with Kaiser Southern California Permanente Medical Group

* REG-MDXHEALTH ANNOUNCES SERVICE AGREEMENT WITH KAISER SOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP

BRIEF-Mdxhealth announced Mvz Dr. Stein & Kollegen to offer the SelectMDx for prostate cancer test

* MVZ DR. STEIN & KOLLEGEN FIRST GERMAN MEDICAL LABORATORY TO OFFER THE SELECTMDX FOR PROSTATE CANCER TEST

Select another date: